- Telehealth visits
- Insurance plan information
Kristi Choy, OD
Optometry • Pediatric Optometry- Telehealth visits
- Insurance plan information
Kristi Choy, OD
Optometry • Pediatric Optometry- Telehealth visits
- Insurance plan information
On this page
About me
Dr. Kristi Choy is an optometrist who provides patients of all ages with comprehensive eye examinations. She has a special interest in working with infants and children, and believes that early intervention for pediatric visual disorders can help ensure the best outcomes.
Choy manages pediatric eye disorders, including amblyopia (sometimes called lazy eye) and strabismus (misalignment of the eyes). She has a particular interest in controlling myopia (nearsightedness), which she treats with eye drops or specialty contact lenses.
Choy earned her doctor of optometry degree at the University of California, Berkeley School of Optometry, where she also completed a residency in pediatric optometry and primary care.
Choy is passionate about volunteering both locally and abroad to help deliver eye care to underserved communities.
Education & training
Residency
- Pediatric Optometry, UC Berkeley School of Optometry
Degree
- OD, UC Berkeley School of Optometry
My expertise
Specialties
- Optometry
- Pediatric Optometry
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223681%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223681%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.